Karyopharm Therapeutics Inc. 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
WEG KENNETH E
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2017-06-15+17,000→ 17,000 totalExercise: $9.18Exp: 2027-06-14→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date.